- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03657615
Hearing Aid Impact on Chronic Tinnitus Patients Evaluated by Resting State PET.
Hearing Aid Impact on Chronic Tinnitus Patients With Associated Hearing Loss Evaluated by Resting State Positron Emission Tomography (PET).
Study Overview
Detailed Description
Subjects are selected as they are enrolled in the Tinnitus Research Group between January 2014 and September 2018. The study was approved by the local medical ethics committee for research at the Medical School of University of São Paulo - protocol number 611.174 in April, 2014.
All the procedures were performed after medical evaluation and a complete tinnitus evaluation protocol, which included somatosensory assessment, self-related questionnaires for tinnitus and hearing: Tinnitus Handicap Inventory (THI), Hearing Handicap Inventory for Adults (HHIA), and , for anxiety and depression symptoms: Generalized Anxiety Depression Scale (GAD-7) and Patient Health Questionnaire (PHQ-9), and for neck pain (Neck Disability Index, NDI). The subjects of this study were also blood tested for pregnancy and diabetes, which may interfere on fluorodeoxyglucose (FDG)-positron emission tomography PET acquisition.
All subjects underwent hearing and tinnitus evaluation, counseling and hearing aid fitting.
To prescribe and verify acoustic response, we used the HA fitting protocol recommended by the National Acoustics Laboratories (NAL), named NAL NL-2 (NL-non linear) FDG-PET measurements were obtained at baseline (prior to HA fitting) and after 6 months of HA use.
Regarding FDG-PET images, a within-subject analysis was performed by comparing pre-treatment and post-treatment group using paired-t-tests.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sao Paulo
-
São Paulo, Sao Paulo, Brazil, 05403000
- Recruiting
- University of Sao Paulo
-
Contact:
- Jeanne Oiticica, MD PhD
- Phone Number: +551130880299
- Email: jeanneramalho@uol.com.br
-
Contact:
- Juliana Anauate, MD
- Phone Number: +5511982921245
- Email: juliana.anauate@gmail.com
-
Principal Investigator:
- Patricia Simonetti, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria::
- chronic perception of tinnitus for more than 6 months;
- THI score greater than 38;
- bilateral and symmetric hearing loss not exceeding 70 decibels (dB) hearing threshold;
- no previous experience with HA. -
Exclusion Criteria:
- unilateral, mixed or conductive hearing loss;
- pulsatile or myoclonic tinnitus;;
- anxiety and depression detected by GAD-7 and PHQ-9;
- significant visual, motor or cognitive deficits;
- pregnant women and diabetic patients
- history of drug abuse -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Hearing Aid Fitting Patients with hearing loss but no tinnitus paired by age and hearing loss degree Hearing aided fitted PET image acquisition before and after 6 months og Hearing aid usage.
|
All patients were fitted bilaterally with hearing aids for hearing loss compensation. .
Apart from different HAs used, device selection followed strict criteria to fit hearing loss demands, patient profile, resources and algorithms recommended for tinnitus patients.
Other Names:
|
Experimental: Tinnitus
Hearing Aid Fitting Patients with tinnitus and hearing loss associated Hearing aided fitted PET image acquisition before and after 6 months og Hearing aid usage.
|
All patients were fitted bilaterally with hearing aids for hearing loss compensation. .
Apart from different HAs used, device selection followed strict criteria to fit hearing loss demands, patient profile, resources and algorithms recommended for tinnitus patients.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PET RESULTS
Time Frame: 6 months
|
After an individual whole brain analysis, a within-subject analysis was performed by comparing pre-treatment and post-treatment situation.
The analysis revealed increased and decreased glycolytic metabolism areas for each subject, after intervention.
For group analysis we used paired-t-tests.
These analyses produced parametric statistical maps, which were then converted into a normal distribution unit (Z-scores).
The significance threshold was set at p<0.05, and corrected for multiple comparisons (FWE or family-wise error rate), either at the voxel or cluster-level.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tinnitus Handicap Inventory (THI)
Time Frame: 6 months
|
The THI consists of 25 questions distributed on three scales that evaluate different tinnitus aspects: functional, emotional and catastrophic.
The options for responding to THI questions are: yes (4 points), sometimes (2 points), and no (0 points).
On a scale from 0-100, 0-16 points signifies negligible tinnitus, 18-36 signifies mild tinnitus, 38-56 signifies moderate tinnitus, 58-76 signifies severe tinnitus, and 78-100 signifies catastrophic tinnitus.
Reductions on scale signifies tinnitus perception are reduced.Results of self-assessment questionnaires and their respective subscales were described according to the follow up evaluation moment.
They were all analyzed statistically.
|
6 months
|
Hearing Handicap Inventory for Adults (HHIA)
Time Frame: 6 months
|
Composed of 25 questions that evaluate social and emotional aspects of hearing disability.
Subjects had three choices: yes (4 points), sometimes (2 points) and no (0 points).
On a scale from zero to 100, scores higher than 44 points indicate severe handicap, from 18-42 points indicate moderate handicap and below 18 indicate no handicap.
After intervention, reductions on scale means less hearing handicap.Results of self-assessment questionnaires and their respective subscales were described according to the follow up evaluation moment.
They were all analyzed statistically.
|
6 months
|
Visual Analog Scale ( VAS)
Time Frame: 6 months
|
The VAS is a numeric scale ranging from 0-10.
Subjects assigned a value to tinnitus annoyance based on this visual scale.
High scores means high degree of tinnitus annoyance.Results were described according to the follow up evaluation moment.
and then analyzed statistically.
|
6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- USaoPauloCF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Tinnitus
-
Philipps University Marburg Medical CenterLinkoeping University; Eriksholm Research Centre; University Hospital of Gießen...CompletedTinnitus | Subjective Tinnitus | Chronic TinnitusGermany
-
State University of New York at BuffaloUniversity at BuffaloCompletedTinnitus, Subjective | Tinnitus | Noise Induced Tinnitus | Tinnitus, Objective | Tinnitus Aggravated | Tinnitus, Pulsatile | Tinnitus, Spontaneous Oto-Acoustic Emission | Tinnitus, Clicking | Tinnitus, Tensor Tympani InducedUnited States
-
University of RegensburgRecruitingChronic TinnitusGermany
-
University of RegensburgCompleted
-
University of RegensburgCompletedChronic TinnitusGermany
-
University of RegensburgCompletedChronic TinnitusGermany
-
University of RegensburgCompleted
-
University of RegensburgCompletedChronic TinnitusGermany
-
Berthold Langguth, MD, Ph.D.Otosul -Otorrinolaringologia Sul-FluminenseCompletedChronic Tinnitus
-
University of RegensburgUniversity Hospital Muenster; University Hospital Tuebingen; University of WuerzburgCompleted
Clinical Trials on hearing aid fitting
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Steward St. Elizabeth's Medical Center of Boston...RecruitingSensorineural Hearing LossUnited States
-
Northwestern UniversityUniversity of Colorado, BoulderEnrolling by invitation
-
hearX GroupCompletedHearing LossSouth Africa
-
VA Office of Research and DevelopmentCompleted
-
Sonova AGWestern University, CanadaCompleted
-
San Diego State UniversityUniversity of California, San DiegoWithdrawn
-
Cambridge University Hospitals NHS Foundation TrustAdvanced Bionics AGCompletedHearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing LossUnited Kingdom
-
Phonak AG, SwitzerlandCompletedValidation StudiesSwitzerland